These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 9613940)
21. Guanidino compounds in serum, urine, liver, kidney, and brain of man and some ureotelic animals. Marescau B; Deshmukh DR; Kockx M; Possemiers I; Qureshi IA; Wiechert P; De Deyn PP Metabolism; 1992 May; 41(5):526-32. PubMed ID: 1588833 [TBL] [Abstract][Full Text] [Related]
22. Serum guanidino compound levels and the influence of a single hemodialysis in uremic patients undergoing maintenance hemodialysis. De Deyn P; Marescau B; Lornoy W; Becaus I; Van Leuven I; Van Gorp L; Lowenthal A Nephron; 1987; 45(4):291-5. PubMed ID: 3587469 [TBL] [Abstract][Full Text] [Related]
23. The generation of lucigenin chemiluminescence from the reaction of guanidino compounds with phenylglyoxal under alkaline conditions and its application. Nohara Y; Usui T; Suzuki J; Hanai T; Kinoshita T; Nakagomi K; Watanabe M Chem Pharm Bull (Tokyo); 2009 Jul; 57(7):700-3. PubMed ID: 19571414 [TBL] [Abstract][Full Text] [Related]
24. Serum guanidino compound levels and clearances in uremic patients treated with continuous ambulatory peritoneal dialysis. De Deyn PP; Marescau B; Swartz RD; Hogaerth R; Possemiers I; Lowenthal A Nephron; 1990; 54(4):307-12. PubMed ID: 2325795 [TBL] [Abstract][Full Text] [Related]
25. Separation of anionic and cationic compounds of biomedical interest by high-performance liquid chromatography on porous graphitic carbon. Gu GH; Lim CK J Chromatogr; 1990 Aug; 515():183-92. PubMed ID: 2178167 [TBL] [Abstract][Full Text] [Related]
26. Guanidino compounds in serum and cerebrospinal fluid of non-dialyzed patients with renal insufficiency. De Deyn PP; Marescau B; Cuykens JJ; Van Gorp L; Lowenthal A; De Potter WP Clin Chim Acta; 1987 Jul; 167(1):81-8. PubMed ID: 3665089 [TBL] [Abstract][Full Text] [Related]
27. [Determination of dencichine in sanchi using liquid chromatography on porous graphitic carbon column]. Fu C; Liu S; Li Z Se Pu; 2007 Nov; 25(6):834-7. PubMed ID: 18257299 [TBL] [Abstract][Full Text] [Related]
28. Convulsive action and toxicity of uremic guanidino compounds: behavioral assessment and relation to brain concentration in adult mice. D'Hooge R; Pei YQ; Marescau B; De Deyn PP J Neurol Sci; 1992 Oct; 112(1-2):96-105. PubMed ID: 1469446 [TBL] [Abstract][Full Text] [Related]
29. High-performance liquid chromatographic measurement of guanidino compounds of clinical importance in human urine and serum by pre-column fluorescence derivatization using benzoin. Kai M; Miyazaki T; Ohkura Y J Chromatogr; 1984 Nov; 311(2):257-66. PubMed ID: 6520173 [TBL] [Abstract][Full Text] [Related]
30. Improved Gas Chromatographic Determination of Guanidino Compounds Using Isovaleroylacetone and Ethyl Chloroformate as Derivatizing Reagents. Zounr RA; Khuhawar MY; Jahangir TM; Alamgir M Anal Sci; 2016; 32(2):141-6. PubMed ID: 26860556 [TBL] [Abstract][Full Text] [Related]
31. Chromatography of guanidino compounds. Hanai T; Inamaoto Y; Inamoto S J Chromatogr B Biomed Sci Appl; 2000 Sep; 747(1-2):123-38. PubMed ID: 11103903 [TBL] [Abstract][Full Text] [Related]
32. Significance of guanidino compounds in non-dialyzed patients with chronic renal failure. Ikezaki N Nihon Jinzo Gakkai Shi; 1990 Mar; 32(3):283-90. PubMed ID: 2355664 [TBL] [Abstract][Full Text] [Related]
33. Liquid-chromatographic determination of guanidino compounds in plasma and erythrocyte of normal persons and uremic patients. Kikuchi T; Orita Y; Ando A; Mikami H; Fujii M; Okada A; Abe H Clin Chem; 1981 Nov; 27(11):1899-902. PubMed ID: 7296840 [TBL] [Abstract][Full Text] [Related]
34. Determination of N-nitrosodiethanolamine, NDELA in cosmetic ingredients and products by mixed mode solid phase extraction and UPLC-tandem mass spectrometry with porous graphitic carbon column through systemic sample pre-cleanup procedure. Joo KM; Shin MS; Jung JH; Kim BM; Lee JW; Jeong HJ; Lim KM Talanta; 2015 May; 137():109-19. PubMed ID: 25770613 [TBL] [Abstract][Full Text] [Related]
35. Serum guanidino compound levels in uremic pediatric patients treated with hemodialysis or continuous cycle peritoneal dialysis. Correlations between nerve conduction velocities and altered guanidino compound concentrations. De Deyn PP; Robitaille P; Vanasse M; Qureshi IA; Marescau B Nephron; 1995; 69(4):411-7. PubMed ID: 7777105 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of fused-core and monolithic versus porous silica-based C18 columns and porous graphitic carbon for ion-pairing liquid chromatography analysis of catecholamines and related compounds. Chirita RI; Finaru AL; Elfakir C J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Mar; 879(9-10):633-40. PubMed ID: 21345749 [TBL] [Abstract][Full Text] [Related]
37. Guanidino compound levels in the serum of healthy adults and epileptic patients. Shiraga H; Watanabe Y; Mori A Epilepsy Res; 1991 Mar; 8(2):142-8. PubMed ID: 1712286 [TBL] [Abstract][Full Text] [Related]
39. Automatic system for the assay of guanidino compounds to assess uremic status. Nohara Y; Hanai T; Suzuki J; Matsumoto G; Iinuma F; Kubo H; Kinoshita T; Watanabe M Biol Pharm Bull; 2000 Sep; 23(9):1015-20. PubMed ID: 10993196 [TBL] [Abstract][Full Text] [Related]
40. A sensitive method for the separation and quantification of low-level adenine nucleotides using porous graphitic carbon-based liquid chromatography and tandem mass spectrometry. Bustamante S; Gilchrist RB; Richani D J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Sep; 1061-1062():445-451. PubMed ID: 28820983 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]